This WLF Litigation Division feature highlights WLF court and agency filings, as well as decisions issued in response to WLF’s filings. In this edition, we list July 2025 filings and outcomes.

Click on the PDF button above for the full report.

NEW WLF FILINGS

  • WLF urges the Ninth Circuit to grant en banc review and reverse a panel decision certifying a sprawling civil-RICO class action.  (Painters Fund v. Takeda Pharmaceutical Co.)
  • WLF asks the D.C. Circuit to clarify that the International Emergency Economic Powers Act does not authorize the President to impose tariffs. (Learning Resources v. Trump)
  • WLF urges the Third Circuit to declare the False Claims Act’s qui tam provisions unconstitutional. (United States ex rel. Penelow v. Janssen Products)
  • WLF opposes the FDA’s latest front-of-package labeling rule. (In re FDA’s Front-of-Package Labeling Rule)
  • WLF asks Supreme Court to uphold federal preemption in auto-lessor liability case. (Malco Enterprises v. Woldeyohannes)
  • WLF reminds the Ninth Circuit that only statutory text and plan documents determine fiduciary duties under ERISA. (Hutchins v. HP Inc.)
  • WLF urges the Supreme Court to avoid wasteful state-court do-over in federal removal dispute. (Hain Celestial Group v. Palmquist)

 ACTIVITY IN WLF CASES

  • The Ninth Circuit affirms a controversial verdict and sweeping injunction in a major antitrust case. (Epic v. Google)